No Prescription |
 |
 | ||
|
Klomen Clomid |
|
| ||
No Prescription » Prescription Drugs 9 » Klomen Clomid Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Gonaphene tablets contain the active ingredient clomifene citrate (previously spelt clomiphene in the UK). (NB. Clomifene is also available without a brand name ie as the generic medicine.)Clomifene works by causing an increase in the levels of hormones in the female body which control the development and release of an egg. These hormones are released from the pituitary gland in the brain and are known as follicle stimulating hormone (FSH) and luteinising hormone (LH). FSH stimulates the ovaries and LH causes the release of an egg from the ovaries (ovulation).Oestrogen normally causes the brain to stop releasing FSH and LH following ovulation as part of the normal menstrual cycle. It does this by acting on receptors in a part of the brain called the hypothalamus which sends messages to the pituitary gland.Clomifene works by blocking the oestrogen receptors in the hypothalamus. This stops oestrogen from acting on these receptors and therefore stops the message being sent to the pituitary gland. This results in the release of more FSH and LH from the pituitary gland. The increase in these hormones increases the chances of egg development and ovulation.Clomifene is used to stimulate ovulation in women whose infertility is due to problems with ovulation.What is it used for?Infertility in women caused by failure of ovulation Buy Klomen Clomid and other Prescription Drugs 9 products online at Medstore. 4974
About Klomen Clomid: Product Type: Prescription Drugs 9 Klomen ( Clomid Generic Clomiphene citrate ) Klomen (Clomid Generic Clomiphene citrate) Clomid Generic Clomiphene citrate 50 mg 10 tabs Clomid Generic Clomiphene citrate Klomen
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
